Although ERβ plays an important role in CLPTM1L-mediated radioresistance, knockdown of ERβ is not a feasible radiosensitizing method at the moment, because multiple functions of ERβ were still elusive in lung cancer. The gene discussed is ESR2; the disease is lung carcinoma.